Role of protein tyrosine phosphatase-1B in diabetes and obesity

被引：40

作者：

Kennedy, BP ^{[1
]}

机构：

[1] Merck Frosst Ctr Therapeut Res, Dept Biochem & Mol Biol, Pointe Claire, PQ H9R 4P8, Canada

来源：

BIOMEDICINE & PHARMACOTHERAPY | 1999年 / 53卷 / 10期

关键词：

obesity; PTP-1B; type; 2; diabetes;

D O I：

10.1016/S0753-3322(00)88105-6

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

Type 2 or non-insulin-dependent diabetes mellitus (NIDDM) is reaching epidemic proportions in industrialized countries. Obesity is a major factor in this disease, since about 75% of obese individuals will develop type 2 diabetes. There is an urgent need to develop new therapies for these diseases. Recently, the protein tyrosine phosphatase PTP-1B has been shown to he a negative regulator of the insulin signaling pathway, suggesting that inhibitors of this enzyme may be beneficial in the treatment of type 2 diabetes. Mice lacking PTP-1B are resistant to both diabetes and obesity. (C) 1999 Editions scientifques et medicales Elsevier SAS.

引用

页码：466 / 470

页数：5

共 35 条

[21] VANADATE STIMULATES INVIVO GLUCOSE-UPTAKE IN BRAIN AND ARRESTS FOOD-INTAKE AND BODY-WEIGHT GAIN IN RATS [J].

MEYEROVITCH, J ;

SHECHTER, Y ;

AMIR, S .

PHYSIOLOGY & BEHAVIOR, 1989, 45 (06) :1113-1116

[22] VANADATE NORMALIZES HYPERGLYCEMIA IN 2 MOUSE MODELS OF NON-INSULIN-DEPENDENT DIABETES-MELLITUS [J].

MEYEROVITCH, J ;

ROTHENBERG, P ;

SHECHTER, Y ;

BONNERWEIR, S ;

KAHN, CR .

JOURNAL OF CLINICAL INVESTIGATION, 1991, 87 (04) :1286-1294

[23] Vanadium and diabetes [J].

Poucheret, P ;

Verma, S ;

Grynpas, MD ;

McNeill, JH .

MOLECULAR AND CELLULAR BIOCHEMISTRY, 1998, 188 (1-2) :73-80

[24] Transgenic mice deficient in the LAR protein-tyrosine phosphatase exhibit profound defects in glucose homeostasis [J].

Ren, JM ;

Li, PM ;

Zhang, WR ;

Sweet, LJ ;

Cline, G ;

Shulman, GI ;

Livingston, JN ;

Goldstein, BJ .

DIABETES, 1998, 47 (03) :493-497

[25] Impaired mammary gland development and function in mice lacking LAR receptor-like tyrosine phosphatase activity [J].

Schaapveld, RQJ ;

Schepens, HTG ;

Robinson, GW ;

Attema, J ;

Oerlemans, FTJJ ;

Fransen, JAM ;

Streuli, M ;

Wieringa, B ;

Hennighausen, L ;

Hendriks, WJAJ .

DEVELOPMENTAL BIOLOGY, 1997, 188 (01) :134-146

[26] Vanadium salts as insulin substitutes: Mechanisms of action, a scientific and therapeutic tool in diabetes mellitus research [J].

Sekar, N ;

Li, JP ;

Shechter, Y .

CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1996, 31 (5-6) :339-359

[27] Potent and highly selective inhibitors of the protein tyrosine phosphatase 1B [J].

Taing, M ;

Keng, YF ;

Shen, K ;

Wu, L ;

Lawrence, DS ;

Zhang, ZY .

BIOCHEMISTRY, 1999, 38 (12) :3793-3803

[28]

TONKS NK, 1988, J BIOL CHEM, V263, P6722

[29]

van Huijsduijnen RH, 1998, GENE, V225, P1

[30] Protein-protein interaction in insulin signaling and the molecular mechanisms of insulin resistance [J].

Virkamäki, A ;

Ueki, K ;

Kahn, CR .

JOURNAL OF CLINICAL INVESTIGATION, 1999, 103 (07) :931-943

← 1 2 3 4 →